ACAD
ACADIA Pharmaceuticals Inc.Healthcare$22.20
◆ Neutral
Mkt Cap: $3.78B|Float: 126.6M|SI: 6.8%|DTC: 4.8
Data as of market close Apr 2, 2026
IV Rank
76
IV Pctl
33%
HV 20d
44.1%
52W Range
$13-$28
ATR(14)
$0.85
Exp. Move
±10.4%
P/C Ratio
0.55
Earnings
May 6
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
ACAD Key Options Data
- IV Rank
- 76.1%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $20.00
- Expected Move
- ±10.4%
- Put/Call OI
- 0.55
- Net Premium
- $-0.0M
- Spot Price
- $22.20
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.30 | ±10.4% | $19.90 | $24.50 |
| 2026-05-15 | 43 | ±$2.42 | ±10.9% | $19.78 | $24.63 |
| 2026-06-18 | 77 | ±$3.95 | ±17.8% | $18.25 | $26.15 |
| 2026-09-18 | 169 | ±$3.65 | ±16.4% | $18.55 | $25.85 |
| 2027-01-15 | 288 | ±$8.45 | ±38.1% | $13.75 | $30.65 |
Explore ACAD options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.